LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1856, Issue 1, 2015, Pages 151-164

  Bhan, Arunoday ^a   Mandal, Subhrangsu S ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Cancer; Epigenetics; HOTAIR; LncRNA; Non coding RNA

Indexed keywords

BRCA1 PROTEIN; COMPETITIVE ENDOGENOUS RNA; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR; HISTONE DEMETHYLASE; HOX ANTISENSE INTERGENIC RNA; LONG UNTRANSLATED RNA; LYSINE SPECIFIC DEMETHYLASE 1A; MICRORNA; MICRORNA 141; POLYCOMB REPRESSIVE COMPLEX 2; RNA; TRANSCRIPTION FACTOR EZH2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CHROMATIN; HOTAIR LONG UNTRANSLATED RNA, HUMAN;

ADVANCED CANCER; AORTA VALVE DISEASE; AORTIC VALVE CALCIFICATION; BLOOD VESSEL CALCIFICATION; BREAST CANCER; CANCER PROGNOSIS; CARCINOGENESIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME CONDENSATION; COLORECTAL CARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESTROGEN RESPONSIVE ELEMENT; GENE SILENCING; GLIOBLASTOMA; HISTONE DEMETHYLATION; HISTONE METHYLATION; HUMAN; LARYNX SQUAMOUS CELL CARCINOMA; LIVER CELL CARCINOMA; LUNG CARCINOMA; NEOPLASM; NONHUMAN; OSTEOARTHRITIS; OVARY CANCER; OVERALL SURVIVAL; PANCREAS CARCINOMA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION; CHROMATIN; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

CHROMATIN; HUMANS; NEOPLASMS; RNA, LONG NONCODING;

EID: 84938389092     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2015.07.001     Document Type: Review

References (158)

1. Thomas D.J., Rosenbloom K.R., Clawson H., Hinrichs A.S., Trumbower H., Raney B.J., Karolchik D., Barber G.P., Harte R.A., Hillman-Jackson J., Kuhn R.M., Rhead B.L., Smith K.E., Thakkapallayil A., Zweig A.S., Haussler D., Kent W.J. The ENCODE Project at UC Santa Cruz. Nucleic Acids Res. 2007, 35:D663-D667.
2. Banfai B., Jia H., Khatun J., Wood E., Risk B., Gundling W.E., Kundaje A., Gunawardena H.P., Yu Y.B., Xie L., Krajewski K., Strahl B.D., Chen X., Bickel P., Giddings M.C., Brown J.B., Lipovich L. Long noncoding RNAs are rarely translated in two human cell lines. Genome Res. 2012, 22:1646-1657.
3. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
4. Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat. Rev. Drug Discov. 2013, 12:433-446.
5. Bhan A., Mandal S.S. Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem 2014, 9:1932-1956.
6. Ma L., Bajic V.B., Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013, 10:925-933.
7. Chew G.L., Pauli A., Rinn J.L., Regev A., Schier A.F., Valen E. Ribosome profiling reveals resemblance between long non-coding RNAs and 5' leaders of coding RNAs. Development 2013, 140:2828-2834.
8. Guttman M., Russell P., Ingolia N.T., Weissman J.S., Lander E.S. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 2013, 154:240-251.
9. Hube F., Guo J., Chooniedass-Kothari S., Cooper C., Hamedani M.K., Dibrov A.A., Blanchard A.A., Wang X., Deng G., Myal Y., Leygue E. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 2006, 25:418-428.
10. Kondo T., Plaza S., Zanet J., Benrabah E., Valenti P., Hashimoto Y., Kobayashi S., Payre F., Kageyama Y. Small peptides switch the transcriptional activity of Shavenbaby during Drosophila embryogenesis. Science 2010, 329:336-339.
11. Ulveling D., Francastel C., Hube F. Identification of potentially new bifunctional RNA based on genome-wide data-mining of alternative splicing events. Biochimie 2011, 93:2024-2027.
12. Khalil A.M., Guttman M., Huarte M., Garber M., Raj A., Rivea Morales D., Thomas K., Presser A., Bernstein B.E., van Oudenaarden A., Regev A., Lander E.S., Rinn J.L. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. 2009, 106:11667-11672.
13. Yoon J.H., Abdelmohsen K., Kim J., Yang X., Martindale J.L., Tominaga-Yamanaka K., White E.J., Orjalo A.V., Rinn J.L., Kreft S.G., Wilson G.M., Gorospe M. Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat. Commun. 2013, 4:2939.
14. Zhou X., Chen J., Tang W. The molecular mechanism of HOTAIR in tumorigenesis, metastasis, and drug resistance. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46:1011-1015.
15. Hajjari M., Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer Biol. Med. 2015, 12:1-9.
16. Bhan A., Hussain I., Ansari K.I., Bobzean S.A., Perrotti L.I., Mandal S.S. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J. Steroid Biochem. Mol. Biol. 2014, 141C:160-170.
17. Bhan A., Hussain I., Ansari K.I., Kasiri S., Bashyal A., Mandal S.S. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J. Mol. Biol. 2013, 425:3707-3722.
18. Tani H., Mizutani R., Salam K.A., Tano K., Ijiri K., Wakamatsu A., Isogai T., Suzuki Y., Akimitsu N. Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res. 2012, 22:947-956.
19. Schorderet P., Duboule D. Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet. 2011, 7:e1002071.
20. Wu Y., Liu J., Zheng Y., You L., Kuang D., Liu T. Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells. Tumour Biol. 2014, 35:11887-11894.
21. He S., Liu S., Zhu H. The sequence, structure and evolutionary features of HOTAIR in mammals. BMC Evol. Biol. 2011, 11:102.
22. Woo C.J., Kingston R.E. HOTAIR lifts noncoding RNAs to new levels. Cell 2007, 129:1257-1259.
23. Wu Y., Zhang L., Wang Y., Li H., Ren X., Wei F., Yu W., Wang X., Zhang L., Yu J., Hao X. Long noncoding RNA HOTAIR involvement in cancer. Tumor Biol. 2014, 1-8.
24. Zhang J., Zhang P., Wang L., Piao H.L., Ma L. Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46:1-5.
25. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., Goodnough L.H., Helms J.A., Farnham P.J., Segal E., Chang H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
26. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
27. Ciferri C., Lander G.C., Maiolica A., Herzog F., Aebersold R., Nogales E. Molecular architecture of human polycomb repressive complex 2. Elife 2012, 1:e00005.
28. Sharma S., Mandal P., Sadhukhan T., Roy Chowdhury R., Ranjan Mondal N., Chakravarty B., Chatterjee T., Roy S., Sengupta S. Bridging Links between Long Noncoding RNA HOTAIR and HPV Oncoprotein E7 in Cervical Cancer Pathogenesis. Sci. Rep. 2015, 5. 10.1038/srep11724.
29. Tsai M.-C., Manor O., Wan Y., Mosammaparast N., Wang J.K., Lan F., Shi Y., Segal E., Chang H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010, 329:689-693.
30. Wu L., Murat P., Matak-Vinkovic D., Murrell A., Balasubramanian S. Binding Interactions between long noncoding RNA HOTAIR and PRC2 proteins. Biochemistry 2013, 52:9519-9527.
31. Davidovich C., Zheng L., Goodrich K.J., Cech T.R. Promiscuous RNA binding by Polycomb repressive complex 2. Nat. Struct. Mol. Biol. 2013, 20:1250-1257.
32. Chu C., Qu K., Zhong F.L., Artandi S.E., Chang H.Y. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 2011, 44:667-678.
33. Pitera J.E., Smith V.V., Thorogood P., Milla P.J. Coordinated expression of 3' hox genes during murine embryonal gut development: an enteric Hox code. Gastroenterology 1999, 117:1339-1351.
34. Hancarova M., Simandlova M., Drabova J., Petrak B., Koudova M., Havlovicova M., Sedlacek Z. Chromosome 12q13.13 deletions involving the HOXC gene cluster: phenotype and candidate genes. Eur. J. Med. Genet. 2013, 56:171-173.
35. Suemori H., Noguchi S. Hox C cluster genes are dispensable for overall body plan of mouse embryonic development. Dev. Biol. 2000, 220:333-342.
36. Wang L., Zeng X., Chen S., Ding L., Zhong J., Zhao J.C., Sarver A., Koller A., Zhi J., Ma Y., Yu J., Chen J., Huang H. BRCA1 is a negative modulator of the PRC2 complex. EMBO J. 2013, 32:1584-1597.
37. Kaneko S., Li G., Son J., Xu C.-F., Margueron R., Neubert T.A., Reinberg D. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 2010, 24:2615-2620.
38. Lam Y.C., Bowman A.B., Jafar-Nejad P., Lim J., Richman R., Fryer J.D., Hyun E.D., Duvick L.A., Orr H.T., Botas J., Zoghbi H.Y. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
39. Huber J., Cronshagen U., Kadokura M., Marshallsay C., Wada T., Sekine M., Luhrmann R. Snurportin1, an m3G-cap-specific nuclear import receptor with a novel domain structure. EMBO J. 1998, 17:4114-4126.
40. Vinayagam A., Stelzl U., Foulle R., Plassmann S., Zenkner M., Timm J., Assmus H.E., Andrade-Navarro M.A., Wanker E.E. A directed protein interaction network for investigating intracellular signal transduction. Sci. Signal. 2011, 4:rs8.
41. Barrios-Rodiles M., Brown K.R., Ozdamar B., Bose R., Liu Z., Donovan R.S., Shinjo F., Liu Y., Dembowy J., Taylor I.W., Luga V., Przulj N., Robinson M., Suzuki H., Hayashizaki Y., Jurisica I., Wrana J.L. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005, 307:1621-1625.
42. Srikantan S., Tominaga K., Gorospe M. Functional interplay between rna-binding protein HuR and microRNAs. Curr. Protein Pept. Sci. 2012, 13:372-379.
43. Zhang H., Diab A., Fan H., Mani S.K., Hullinger R., Merle P., Andrisani O. PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during Hepatitis B virus-induced liver carcinogenesis. Cancer Res. 2015, 75:2363-2374.
44. Huang J., Ke P., Guo L., Wang W., Tan H., Liang Y., Yao S. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int. J. Gynecol. Cancer 2014, 24:635-642. 10.1097/IGC.0000000000000121.
45. Susiarjo M., Hassold T.J., Freeman E., Hunt P.A. Bisphenol A exposure in utero disrupts early oogenesis in the mouse. PLoS Genet. 2007, 3:e5.
46. Huang T.H., Morrison S.L. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia. J. Pharmacol. Exp. Ther. 2006, 316:983-991.
47. Lemoine N.R., Jain S., Silvestre F., Lopes C., Hughes C.M., McLelland E., Gullick W.J., Filipe M.I. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. Br. J. Cancer 1991, 64:79-83.
48. Faltus T., Yuan J., Zimmer B., Kramer A., Loibl S., Kaufmann M., Strebhardt K. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells. Neoplasia 2004, 6:786-795.
49. Liu X.-h., Sun M., Nie F.-q., Ge Y.-b., Zhang E.-b., Yin D.-d., Kong R., Xia R., Lu K.-h., Li J.-h., De W., Wang K.-m., Wang Z.-x. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol. Cancer 2014, 13:92.
50. Fu W.-M., Zhu X., Wang W.-M., Lu Y.-f., Hu B.-g., Wang H., Liang W.-C., Wang S.-s., Ko C.-H., Waye M.M.-Y., Kung H.-F., Li G., Zhang J.-F. Hotair Mediates Hepatocarcinogenesis through Suppressing MiRNA-218 Expression and Activating P14 and P16 Signaling. J. Hepatol 2015.
51. Xing C.-y., Hu X.-q., Xie F.-y., Yu Z.-j., Li H.-y., Bin Z., Wu J.-b., Tang L.-y., Gao S.-m. Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia, FEBS Lett 2015.
52. Nilsson S., Gustafsson J.A. Estrogen receptor action. Crit. Rev. Eukaryot. Gene Expr. 2002, 12:237-257.
53. Nilsson S., Gustafsson J.A. Estrogen receptor transcription and transactivation: basic aspects of estrogen action. Breast Cancer Res. 2000, 2:360-366.
54. Ansari K.I., Hussain I., Kasiri S., Mandal S.S. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4. J. Mol. Endocrinol. 2012, 48:61-75.
55. Ansari K.I., Kasiri S., Hussain I., Bobzean S.A., Perrotti L.I., Mandal S.S. MLL histone methylases regulate expression of HDLR-SR-B1 in presence of estrogen and control plasma cholesterol in vivo. Mol. Endocrinol. 2013, 27:92-105.
56. Ansari K.I., Mishra B.P., Mandal S.S. MLL histone methylases in gene expression, hormone signaling and cell cycle. Front Biosci. (Landmark Ed) 2009, 14:3483-3495.
57. Ansari K.I., Shrestha B., Hussain I., Kasiri S., Mandal S.S. Histone methylases MLL1 and MLL3 coordinate with estrogen receptors in estrogen-mediated HOXB9 expression. Biochemistry 2011, 50:3517-3527.
58. Ansari K.I., Kasiri S., Hussain I., Mandal S.S. Mixed lineage leukemia histone methylases play critical roles in estrogen-mediated regulation of HOXC13. FEBS J. 2009, 276:7400-7411.
59. Lonard D.M., O'Malley B.W. Expanding functional diversity of the coactivators. Trends Biochem. Sci. 2005, 30:126-132.
60. Bhan A., Hussain I., Ansari K.I., Bobzean S.A., Perrotti L.I., Mandal S.S. Histone methyltransferase EZH2 is transcriptionally induced by estradiol as well as estrogenic endocrine disruptors bisphenol-A and diethylstilbestrol. J. Mol. Biol. 2014, 426:3426-3441.
61. Kasiri S., Ansari K.I., Hussain I., Bhan A., Mandal S.S. Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and induces apoptosis in tumor cells and over expression of HOXC13 induces 3D-colony formation. RSC Adv. 2013, 3:3260-3269.
62. Chen B.S., Mandal S.S., Hampsey M. High-resolution protein-DNA contacts for the yeast RNA polymerase II general transcription machinery. Biochemistry 2004, 43:12741-12749.
63. Mandal S.S., Fidalgo da Silva E., Reha-Krantz L.J. Using 2-aminopurine fluorescence to detect base unstacking in the template strand during nucleotide incorporation by the bacteriophage T4 DNA polymerase. Biochemistry 2002, 41:4399-4406.
64. Shibata H., Spencer T.E., Onate S.A., Jenster G., Tsai S.Y., Tsai M.J., O'Malley B.W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 1997, 52:141-164. (discussion 164-145).
65. Watson P.J., Fairall L., Schwabe J.W. Nuclear hormone receptor co-repressors: structure and function. Mol. Cell. Endocrinol. 2012, 348:440-449.
66. Baniahmad A. Nuclear hormone receptor co-repressors. J. Steroid Biochem. Mol. Biol. 2005, 93:89-97.
67. Hussain I., Bhan A., Ansari K.I., Deb P., Bobzean S.A., Perrotti L.I., Mandal S.S. Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer. Biochim. Biophys. Acta 2015, 1849:697-708.
68. Ma M.Z., Li C.X., Zhang Y., Weng M.Z., Zhang M.D., Qin Y.Y., Gong W., Quan Z.W. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol. Cancer 2014, 13:156.
69. Ma Y., Trump D.L., Johnson C.S. Vitamin D and miRNAs in cancer. Curr. Gene Ther. 2014, 14:269-275.
70. ChunJiao S., Huan C., ChaoYang X., GuoMei R. Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer. IUBMB Life 2014, 66:379-386.
71. Villanueva M.T. Tumorigenesis: miRNAs - novel regulators in skin cancer. Nat. Rev. Cancer 2014, 15:5.
72. Ristau J., Staffa J., Schrotz-King P., Gigic B., Makar K.W., Hoffmeister M., Brenner H., Ulrich A., Schneider M., Ulrich C.M., Habermann N. Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 2014, 23:2632-2637.
73. Monroig P.D., Chen L., Zhang S., Calin G.A. Small molecule compounds targeting miRNAs for cancer therapy. Adv. Drug Deliv. Rev. 2015, 81C:104-116.
74. Li S., Zhang J., Wan X. Role of miRNAs in endometrial cancer. Histol. Histopathol. 2014, 30:539-548.
75. Zagryazhskaya A., Zhivotovsky B. miRNAs in lung cancer: a link to aging. Ageing Res. Rev. 2014, 17:54-67.
76. Chen Y., Gao D., Huang L. In vivo delivery of miRNAs for cancer therapy: challenges and strategies. Adv. Drug Deliv. Rev. 2015, 81C:128-141.
77. Wang Y., Liang J., Di C., Zhao G., Zhao Y. Identification of miRNAs as potential new biomarkers for nervous system cancer. Tumour Biol. 2014, 35:11631-11638.
78. Mendell J.T. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005, 4:1179-1184.
79. Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148:1172-1187.
80. Nicoloso M.S., Spizzo R., Shimizu M., Rossi S., Calin G.A. MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 2009, 9:293-302.
81. Chiyomaru T., Fukuhara S., Saini S., Majid S., Deng G., Shahryary V., Chang I., Tanaka Y., Enokida H., Nakagawa M., Dahiya R., Yamamura S. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J. Biol. Chem. 2014, 289:12550-12565.
82. Niinuma T., Suzuki H., Nojima M., Nosho K., Yamamoto H., Takamaru H., Yamamoto E., Maruyama R., Nobuoka T., Miyazaki Y., Nishida T., Bamba T., Kanda T., Ajioka Y., Taguchi T., Okahara S., Takahashi H., Nishida Y., Hosokawa M., Hasegawa T., Tokino T., Hirata K., Imai K., Toyota M., Shinomura Y. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012, 72:1126-1136.
83. Vuorinen A., Odermatt A., Schuster D. In silico methods in the discovery of endocrine disrupting chemicals. J. Steroid Biochem. Mol. Biol. 2013, 137:18-26.
84. Calle E.E., Mervis C.A., Thun M.J., Rodriguez C., Wingo P.A., Heath C.W. Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am. J. Epidemiol. 1996, 144:645-652.
85. Doherty L.F., Bromer J.G., Zhou Y., Aldad T.S., Taylor H.S. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer. Horm. Cancer 2010, 1:146-155.
86. Lee H.R., Hwang K.A., Park M.A., Yi B.R., Jeung E.B., Choi K.C. Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. Int. J. Mol. Med. 2012, 29:883-890.
87. Akbas G.E., Song J., Taylor H.S. A HOXA10 estrogen response element (ERE) is differentially regulated by 17 beta-estradiol and diethylstilbestrol (DES). J. Mol. Biol. 2004, 340:1013-1023.
88. Titus-Ernstoff L., Hatch E.E., Hoover R.N., Palmer J., Greenberg E.R., Ricker W., Kaufman R., Noller K., Herbst A.L., Colton T., Hartge P. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br. J. Cancer 2001, 84:126-133.
89. Eilam-Stock T., Serrano P., Frankfurt M., Luine V. Bisphenol-A impairs memory and reduces dendritic spine density in adult male rats. Behav. Neurosci. 2012, 126:175-185.
90. Hwang H.M., Park E.K., Young T.M., Hammock B.D. Occurrence of endocrine-disrupting chemicals in indoor dust. Sci. Total Environ. 2008, 404:26-35.
91. Shrestha B., Ansari K.I., Bhan A., Kasiri S., Hussain I., Mandal S.S. Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue. FEBS J. 2012, 279:3715-3726.
92. Heubach J., Monsior J., Deenen R., Niegisch G., Szarvas T., Niedworok C., Schulz W.A., Hoffmann M.J. The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells. Mol. Cancer 2015, 14.
93. Kim K., Jutooru I., Chadalapaka G., Johnson G., Frank J., Burghardt R., Kim S., Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013, 32:1616-1625.
94. Ding C., Cheng S., Yang Z., Lv Z., Xiao H., Du C., Peng C., Xie H., Zhou L., Wu J., Zheng S. Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int. J. Mol. Sci. 2014, 15:4060-4076.
95. Geng Y.J., Xie S.L., Li Q., Ma J., Wang G.Y. Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res. 2011, 39:2119-2128.
96. Ishibashi M., Kogo R., Shibata K., Sawada G., Takahashi Y., Kurashige J., Akiyoshi S., Sasaki S., Iwaya T., Sudo T., Sugimachi K., Mimori K., Wakabayashi G., Mori M. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol. Rep. 2013, 29:946-950.
97. Yang Z., Zhou L., Wu L.M., Lai M.C., Xie H.Y., Zhang F., Zheng S.S. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol. 2011, 18:1243-1250.
98. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
99. Svoboda M., Slyskova J., Schneiderova M., Makovicky P., Bielik L., Levy M., Lipska L., Hemmelova B., Kala Z., Protivankova M., Vycital O., Liska V., Schwarzova L., Vodickova L., Vodicka P. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients. Carcinogenesis 2014, 35:1510-1515.
100. Cui L., Xie X.Y., Wang H., Chen X.L., Liu S.L., Hu L.N. Expression of long non-coding RNA HOTAIR mRNA in ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 2013, 44:57-59.
101. Nakayama I., Shibazaki M., Yashima-Abo A., Miura F., Sugiyama T., Masuda T., Maesawa C. Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells. Int. J. Oncol. 2013, 43:63-71.
102. Milhem M.M., Knutson T., Yang S., Zhu D., Wang X., Leslie K.K., Meng X. Correlation of MTDH/AEG-1 and HOTAIR expression with metastasis and response to treatment in sarcoma patients. J. Cancer Sci. Ther. 2011, S5.
103. Chen F.J., Sun M., Li S.Q., Wu Q.Q., Ji L., Liu Z.L., Zhou G.Z., Cao G., Jin L., Xie H.W., Wang C.M., Lv J., De W., Wu M., Cao X.F. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol. Carcinog. 2013, 52:908-915.
104. Ge X.S., Ma H.J., Zheng X.H., Ruan H.L., Liao X.Y., Xue W.Q., Chen Y.B., Zhang Y., Jia W.H. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci. 2013, 104:1675-1682.
105. Li X., Wu Z., Mei Q., Guo M., Fu X., Han W. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Br. J. Cancer 2013, 109:2266-2278.
106. Lv X.B., Lian G.Y., Wang H.R., Song E., Yao H., Wang M.H. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One 2013, 8:e63516.
107. Nie Y., Liu X., Qu S., Song E., Zou H., Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013, 104:458-464.
108. Li D., Feng J., Wu T., Wang Y., Sun Y., Ren J., Liu M. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am. J. Pathol. 2013, 182:64-70.
109. Wang J.T., Zhou Y.D., Lu J.G., Sun Y.N., Xiao H., Liu M., Tian L.L. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med. Oncol. 2014, 31.
110. Li Z., Li C., Liu C., Yu S., Zhang Y. Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. Pituitary 2014, 18:42-47.
111. Chiyomaru T., Yamamura S., Fukuhara S., Yoshino H., Kinoshita T., Majid S., Saini S., Chang I., Tanaka Y., Enokida H., Seki N., Nakagawa M., Dahiya R. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One 2013, 8:e70372.
112. Huang L., Liao L.-M., Liu A.-W., Wu J.-B., Cheng X.-L., Lin J.-X., Zheng M. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer. Arch. Gynecol. Obstet. 2014, 1-7.
113. Slattery M.L., Herrick J.S., Mullany L.E., Valeri N., Stevens J., Caan B.J., Samowitz W., Wolff R.K. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int. J. Cancer 2014, 137:428-438.
114. Tang L.H., Zhang W., Su B., Yu B. Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed. Res. Int. 2013, 2013:1-7.
115. Ishitoya J., Toriyama M., Oguchi N., Kitamura K., Ohshima M., Asano K., Yamamoto T. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br. J. Cancer 1989, 59:559-562.
116. Wang W.T., Chen Y.Q. Circulating miRNAs in cancer: from detection to therapy. J. Hematol. Oncol. 2014, 7:86.
117. He X., Bao W., Li X., Chen Z., Che Q., Wang H., Wan X.P. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int. J. Mol. Med. 2014, 33:325-332.
118. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., Wang Y., Brzoska P., Kong B., Li R., West R.B., van de Vijver M.J., Sukumar S., Chang H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
119. Sorensen K.P., Thomassen M., Tan Q., Bak M., Cold S., Burton M., Larsen M.J., Kruse T.A. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res. Treat. 2013, 142:529-536.
120. Lu L., Zhu G., Zhang C., Deng Q., Katsaros D., Mayne S.T., Risch H.A., Mu L., Canuto E.M., Gregori G., Benedetto C., Yu H. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res. Treat. 2012, 136:875-883.
121. Wang L.J., Chen S.J., Xue M., Zhong J., Wang X., Gan L.H., Lam E.K.Y., Liu X., Zhang J.B., Zhou T.H., Yu J., Jin H.C., Si J.M. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol. Med. 2012, 18:389-400.
122. Ying J., Li H., Seng T.J., Langford C., Srivastava G., Tsao S.W., Putti T., Murray P., Chan A.T.C., Tao Q. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene 2006, 25:1070-1080.
123. Chisholm K.M., Wan Y., Li R., Montgomery K.D., Chang H.Y., West R.B. Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS One 2012, 7:e47998.
124. Stefani M. Generic cell dysfunction in neurodegenerative disorders: role of surfaces in early protein misfolding, aggregation, and aggregate cytotoxicity. Neuroscientist 2007, 13:519-531.
125. Yang G., Zhang S., Gao F., Liu Z., Lu M., Peng S., Zhang T., Zhang F. Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1. Biochim. Biophys. Acta (BBA)-Gene Regulatory Mechanisms 2014, 1839:837-848.
126. Jones D.R., Schmidt R.J., Pickard R.T., Foxworthy P.S., Eacho P.I. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J. Lipid Res. 2002, 43:383-391.
127. Li J.T., Wang L.F., Zhao Y.L., Yang T., Li W., Zhao J., Yu F., Wang L., Meng Y.L., Liu N.N., Zhu X.S., Gao C.F., Jia L.T., Yang A.G. Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis. Breast Cancer Res. 2014, 16:454.
128. Zhang H., Cai K., Wang J., Wang X., Cheng K., Shi F., Jiang L., Zhang Y., Dou J. MiR-7, inhibited indirectly by LincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells 2014, 32:2858-2868.
129. Padua Alves C., Fonseca A.S., Muys B.R., de Barros E.L.B.R., Burger M.C., de Souza J.E., Valente V., Zago M.A., Silva W.A. Brief report: the lincRNA hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 2013, 31:2827-2832.
130. He Y., Meng X.M., Huang C., Wu B.M., Zhang L., Lv X.W., Li J. Long noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer Lett. 2014, 344:20-27.
131. Liu X.H., Liu Z.L., Sun M., Liu J., Wang Z.X., De W. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013, 13:464.
132. Liu Z., Sun M., Lu K., Liu J., Zhang M., Wu W., De W., Wang Z., Wang R. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PLoS One 2013, 8:e77293.
133. Nakagawa T., Endo H., Yokoyama M., Abe J., Tamai K., Tanaka N., Sato I., Takahashi S., Kondo T., Satoh K. Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem. Biophys. Res. Commun. 2013, 436:319-324.
134. Ono H., Motoi N., Nagano H., Miyauchi E., Ushijima M., Matsuura M., Okumura S., Nishio M., Hirose T., Inase N., Ishikawa Y. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med. 2014, 3:632-642.
135. Zhuang Y., Wang X., Nguyen H.T., Zhuo Y., Cui X., Fewell C., Flemington E.K., Shan B. Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J. Hematol. Oncol. 2013, 6:35.
136. Alves C.P., Fonseca A.S., Muys B.R., Bueno R.D.E.L., Burger M.C., de Souza J.E.S., Valente V., Zago M.A., Silva W.A. Brief report: the lincRNA hotair is required for epithelial-to-mesenchymal transition and stemness maintenance of cancer cell lines. Stem Cells 2013, 31:2827-2832.
137. Zhang J.X., Han L., Bao Z.S., Wang Y.Y., Chen L.Y., Yan W., Yu S.Z., Pu P.Y., Liu N., You Y.P., Jiang T., Kang C.S. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma. Neuro. Oncol. 2013, 15:1595-1603.
138. Arita T., Ichikawa D., Konishi H., Komatsu S., Shiozaki A., Shoda K., Kawaguchi T., Hirajima S., Nagata H., Kubota T., Fujiwara H., Okamoto K., Otsuji E. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013, 33:3185-3193.
139. Hajjari M., Behmanesh M., Sadeghizadeh M., Zeinoddini M. Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med. Oncol. 2013, 30:670.
140. Amort T., Souliere M.F., Wille A., Jia X.Y., Fiegl H., Worle H., Micura R., Lusser A. Long non-coding RNAs as targets for cytosine methylation. RNA Biol. 2013, 10:1003-1008.
141. Diederichs S. The four dimensions of noncoding RNA conservation. Trends Genet. 2014, 30:121-123.
142. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012, 9:703-719.
143. Isin M., Ozgur E., Cetin G., Erten N., Aktan M., Gezer U., Dalay N. Investigation of circulating lncRNAs in B-cell neoplasms. Clin. Chim. Acta 2014, 431:255-259.
144. Jalali S., Bhartiya D., Lalwani M.K., Sivasubbu S., Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One 2013, 8:e53823.
145. Kitagawa M., Kotake Y., Ohhata T. Long non-coding RNAs involved in cancer development and cell fate determination. Curr. Drug Targets 2012, 13:1616-1621.
146. Schiavo G., D'Anto V., Cantile M., Procino A., Di Giovanni S., Valletta R., Terracciano L., Baumhoer D., Jundt G., Cillo C. Deregulated HOX genes in ameloblastomas are located in physical contiguity to keratin genes. J. Cell. Biochem. 2011, 112:3206-3215.
147. Shi X., Sun M., Liu H., Yao Y., Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013, 339:159-166.
148. Wutz A. RNA-mediated silencing mechanisms in mammalian cells. Prog. Mol. Biol. Transl. Sci. 2011, 101:351-376.
149. Li C.H., Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int. J. Biochem. Cell Biol. 2013, 45:1895-1910.
150. Gao J.J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., Sun Y.C., Jacobsen A., Sinha R., Larsson E., Cerami E., Sander C., Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013, 6.
151. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., Antipin Y., Reva B., Goldberg A.P., Sander C., Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2:401-404.
152. Carrion K., Dyo J., Patel V., Sasik R., Mohamed S.A., Hardiman G., Nigam V. The long non-coding HOTAIR is modulated by cyclic stretch and WNT/beta-CATENIN in human aortic valve cells and is a novel repressor of calcification genes. PLoS One 2014, 9.
153. Madarnas Y., Trudeau M., Franek J.A., McCready D., Pritchard K.I., Messersmith H. Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review. Cancer Treat. Rev. 2008, 34:539-557.
154. Zou Y.F., Sun L.Z. Long noncoding RNA HOTAIR modulates the function of trophoblast cells in pre-eclampsia. Sichuan Da Xue Xue Bao Yi Xue Ban 2015, 46:113-117. (122).
155. Karpe F., Pinnick K.E. Biology of upper-body and lower-body adipose tissue-link to whole-body phenotypes. Nat. Rev. Endocrinol. 2014, 11:90-100.
156. Li L.J., Liu B., Wapinski O.L., Tsai M.C., Qu K., Zhang J.J., Carlson J.C., Lin M.H., Fang F.Q., Gupta R.A., Helms J.A., Chang H.Y. Targeted disruption of hotair leads to homeotic transformation and gene derepression. Cell Rep. 2013, 5:3-12.
157. Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M.D., Ullrich A., Schlessinger J. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. J. Cell Sci. Suppl. 1985, 3:161-172.
158. Chakravadhanula M., Ozols V.V., Hampton C.N., Zhou L., Catchpoole D., Bhardwaj R.D. Expression of the HOX genes and HOTAIR in atypical teratoid rhabdoid tumors and other pediatric brain tumors. Cancer Genet 2014, 207:425-428.